4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Helix BioPharma Corp. (HBP) operates in the Biotechnology industry and is headquartered in Vancouver, Canada. Its market capitalization is roughly CAD 143 million.
Helix BioPharma Corp. a clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.
Interactive charts & full statements →
| Income statement | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Total Revenue | — | CAD 0M | CAD 0M | CAD 0M |
| Operating Income (EBIT) | — | (CAD 9M) | (CAD 6M) | (CAD 6M) |
| Net Income | — | (CAD 9M) | (CAD 6M) | (CAD 7M) |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|---|---|
| Total Revenue | CAD 0M | CAD 0M | CAD 0M | — | CAD 0M | CAD 0M |
| Operating Income (EBIT) | (CAD 1M) | (CAD 1M) | (CAD 1M) | — | (CAD 2M) | (CAD 1M) |
| Net Income | (CAD 1M) | (CAD 1M) | (CAD 1M) | — | (CAD 2M) | (CAD 1M) |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|
| Total Assets | CAD 2M | CAD 1M | CAD 4M |
| Total Liabilities | CAD 2M | CAD 2M | CAD 3M |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HBP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms